The Latest Analyst Ratings For Hims & Hers Health
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Hims & Hers Health (NYSE:HIMS) over the past three months, with a majority being bullish. The average 12-month price target has increased significantly, indicating positive sentiment. The company has shown strong financial performance with high revenue growth and profitability metrics.
August 22, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health has received mixed analyst ratings, with a majority being bullish. The average price target has increased by 36.75%, reflecting positive sentiment. The company shows strong financial health with significant revenue growth and profitability.
The majority of analysts have a bullish outlook on Hims & Hers Health, with an increased average price target indicating positive sentiment. The company's strong financial performance, including high revenue growth and profitability, supports a likely positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100